Genetic model predicts risk for common deadly diseases
Using data collected from the UK, the data suggests that up to 25 million people in the US may be at more than triple the risk of coronary artery disease...
List view / Grid view
Using data collected from the UK, the data suggests that up to 25 million people in the US may be at more than triple the risk of coronary artery disease...
The team found that colistin worked well with protein synthesis inhibitor antibiotics, which alone have no activity against Gram-negative bacteria...
Researchers have developed high-tech tools to uncover the genetic cause of the most difficult to diagnose cases...
Results using mouse models suggest that vasoactive intestinal peptide may provide a new method of improving the outcomes of corneal transplant surgery...
The main areas identified to hinder NGS market growth are the lack of skilled professionals and complications relating to data storage...
Congestive heart failure is a terminal disease that affects nearly 6 million people in the U.S.; yet its management is limited to symptomatic treatments as its causal mechanisms – including its most common form, ischemic cardiomyopathy – are unknown.
New research shows that immune cells developed from early exposure to bacteria contribute to vision loss in glaucoma patients...
PARP inhibitors show promise in preventing toxic accumulations of brain disease proteins in Penn research study...
A team of neuropathologists worked together to show that the impairments affecting mitochondria also affect neighbouring organelles...
VSV acted as a vehicle to deliver the genes of some proteins from the Zika virus into mouse models, leading to immunity build up in the mice...
Germ line genetic testing analyses blood samples and evaluates inherited genetic changes that increase the risk of certain cancers in an individual...
Researchers have identified a gene that when inhibited, reduced human non-small cell lung cancer tumours from growing...
"Targeted therapies have revolutionised cancer treatment by targeting fewer components within a human cell, thereby promising better efficacy..."
The new class of drugs are mechanism-based inhibitors which potentially interrupt the gut microbial pathway that produces TMAO...
Genome editing using the CRISPR-Cas9 system has tremendous promise for therapeutic correction of genetic errors in human cells...